Indsoya Rights Issue 2025 vs Kilitch Drugs (india) Rights Issue 2025

Comparison between Indsoya Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Indsoya Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025. Indsoya Rights Issue 2025 is listed on BSE while Kilitch Drugs (india) Rights Issue 2025 is listed on BSE, NSE.

 Indsoya LtdKilitch Drugs (india) Ltd.
LogoIndsoya Rights Issue 2025 LogoKilitch Drugs (india) Rights Issue 2025 Logo
Listing AtBSEBSE, NSE
Terms of Payment

Full amount of Rs.5/- per Equity Share is payable on application.

The full amount of the Issue Price Rs 357/- will be payable on application.

Entitlement25 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date2 Rights Equity Share(s) for every 23 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Indsoya Rights Issue 2025 rights issue is ₹5.00 Crores, whereas Kilitch Drugs (india) Rights Issue 2025 rights issue size is ₹49.93 Crores.

 Indsoya LtdKilitch Drugs (india) Ltd.
Issue Size1,00,00,000 shares13,98,463 shares
Issue Size (Amount)₹5.00 Crores₹49.93 Crores
Issue Price₹5 per share₹357 per share
Face Value₹5 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Indsoya Rights Issue 2025 is Jul 07, 2025 while record date of Kilitch Drugs (india) Rights Issue 2025 is Jul 15, 2025.

 Indsoya LtdKilitch Drugs (india) Ltd.
Record DateJul 07, 2025Jul 15, 2025
Credit of Rights EntitlementsJul 15, 2025Jul 16, 2025
Bid/Offer Opens OnJul 16, 2025Jul 23, 2025
Renunciation of Rights EntitlementsJul 23, 2025Aug 18, 2025
Bid/Offer Closes OnJul 29, 2025Aug 21, 2025
Deemed Date of AllotmentAug 04, 2025Aug 22, 2025
Credit DateAug 08, 2025Aug 26, 2025
Listing DateAug 13, 2025Aug 28, 2025

Financials details

Comparison of Indsoya Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Indsoya LtdKilitch Drugs (india) Ltd.
Financial

Apollo Ingredients Limited Financial Information (Restated)

Apollo Ingredients Limited's revenue increased by 207% and profit after tax (PAT) rose by 60% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Assets1.671,72,418.501.161.21
Revenue3.081.000.032.49
Profit After Tax0.100.06-0.070.06
Reserves and Surplus0.980.92
Amount in ₹ Crore

Kilitch Drugs (india) Ltd. Financial Information (Restated Consolidated)

Kilitch Drugs (india) Ltd.'s revenue increased by 28% and profit after tax (PAT) rose by 84% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue198.32154.37
Profit After Tax24.9413.58
Net Worth202.33176.29
Reserves and Surplus186.25160.21
Amount in ₹ Crore

Compare with others

Compare:

Indsoya Rights Issue 2025 Vs Kilitch Drugs (india) Rights Issue 2025